TrialThe lancet. HIV2018

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.

Linda-Gail Bekker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.